\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Agro-Food, Environment EIT MissionsThe EIT will launch a new Knowledge and Innovation Community (KIC) in the water, marine and maritime sectors and ecosystems. The new EIT KIC will develop an integrated approach across freshwater, marine and maritime sectors, supporting entrepreneurial education and skills development, innovation projects as well as the ideation, development, deployment and commercialisation of new technologies, products and services.
At the beginning of 2025, the EIT will publish a call for proposals inviting applicants to submit their vision for EIT Water. In line with the EIT Strategic Innovation Agenda, the new KIC will be selected in 2025 and launched in 2026. Read more - here.
To provide interested organisations with more information about the EIT’s upcoming Call for Proposals, the EIT is hosting a series of online info seminars in autumn 2024:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
